Open AccessReply to Comment on “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US”
Author(s) -
William V. Padula,
Sonal Parasrampuria,
Mariana P. Socal,
Rena M. Conti,
Gerard F. Anderson
Publication year - 2020
Publication title -
pharmacoeconomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.809
H-Index - 100
eISSN - 1179-2027
pISSN - 1170-7690
DOI - 10.1007/s40273-020-00973-9
Subject(s) - orphan drug , health economics , quality of life research , drug approval , pharmacoeconomics , public health , business , public economics , medicine , economics , pharmacology , intensive care medicine , drug , bioinformatics , nursing , biology